Multiple Sclerosis, An Issue of Neurologic Clinics: The Clinics: Internal Medicine, cartea 42-1
Editat de Carrie M. Hershen Limba Engleză Hardback – 21 noi 2023
Din seria The Clinics: Internal Medicine
- 5% Preț: 546.14 lei
- 5% Preț: 591.22 lei
- 5% Preț: 403.22 lei
- 5% Preț: 547.10 lei
- 5% Preț: 547.46 lei
- 5% Preț: 518.41 lei
- 5% Preț: 518.63 lei
- 5% Preț: 518.68 lei
- 5% Preț: 518.97 lei
- 5% Preț: 519.45 lei
- 5% Preț: 517.99 lei
- 5% Preț: 519.60 lei
- 5% Preț: 332.71 lei
- 5% Preț: 403.11 lei
- 5% Preț: 402.77 lei
- 5% Preț: 403.05 lei
- 5% Preț: 402.97 lei
- 5% Preț: 388.02 lei
- 5% Preț: 463.35 lei
- 5% Preț: 403.45 lei
- 5% Preț: 460.61 lei
- 5% Preț: 405.53 lei
- 5% Preț: 402.77 lei
- 5% Preț: 460.70 lei
- 5% Preț: 462.58 lei
- 5% Preț: 295.32 lei
- 5% Preț: 448.61 lei
- 5% Preț: 506.71 lei
- 5% Preț: 402.08 lei
- 5% Preț: 402.52 lei
- 5% Preț: 402.52 lei
- 5% Preț: 519.16 lei
- 5% Preț: 518.40 lei
- 5% Preț: 614.05 lei
- 5% Preț: 518.22 lei
- 5% Preț: 518.11 lei
- 21% Preț: 450.00 lei
- 21% Preț: 448.67 lei
- 5% Preț: 576.45 lei
- 5% Preț: 576.18 lei
- 5% Preț: 577.93 lei
- 5% Preț: 576.95 lei
- 5% Preț: 576.12 lei
- 5% Preț: 570.08 lei
- 5% Preț: 547.44 lei
- 5% Preț: 686.26 lei
- 5% Preț: 726.27 lei
- 5% Preț: 576.28 lei
- 5% Preț: 579.23 lei
- 5% Preț: 576.18 lei
Preț: 579.40 lei
Preț vechi: 609.89 lei
-5% Nou
Puncte Express: 869
Preț estimativ în valută:
110.87€ • 120.81$ • 93.42£
110.87€ • 120.81$ • 93.42£
Carte disponibilă
Livrare economică 03-17 aprilie
Livrare express 19-25 martie pentru 44.31 lei
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780323939171
ISBN-10: 0323939171
Pagini: 240
Dimensiuni: 152 x 229 x 143 mm
Greutate: 0.7 kg
Editura: Elsevier
Seria The Clinics: Internal Medicine
ISBN-10: 0323939171
Pagini: 240
Dimensiuni: 152 x 229 x 143 mm
Greutate: 0.7 kg
Editura: Elsevier
Seria The Clinics: Internal Medicine
Cuprins
Multiple Sclerosis Diagnostic Delay and Misdiagnosis
Recent Advances in Diagnostic, Prognostic, and Disease-Monitoring Biomarkers in Multiple Sclerosis
Pathophysiology, Diagnosis, Treatment and Emerging Neurotherapeutic Targets for Progressive Multiple Sclerosis: The Age of PIRA
Relationship Between Multiple Sclerosis, Gut Dysbiosis, and Inflammation: Considerations for Treatment
Updates in NMOSD and MOGAD Diagnosis and Treatment: A Tale of Two Central Nervous System Autoimmune Inflammatory Disorders
Advances in Multiple Sclerosis Neurotherapeutics, Neuroprotection, and Risk Mitigation Strategies
Role of B Cells in Relapsing-Remitting and Progressive Multiple Sclerosis and Long-Term Effects of B Cell Depletion
Bruton's Tyrosine Kinase Inhibitors for Multiple Sclerosis Treatment: A New Frontier
Autologous Hematopoietic Stem Cell Transplantation to Treat Multiple Sclerosis
Highly Effective Therapy Versus Escalation Approaches in Early Multiple Sclerosis: What Is the Future of Multiple Sclerosis Treatment?
Leveraging Real-World Evidence and Observational Studies in Treating Multiple Sclerosis
Health, Wellness, and the Effect of Comorbidities on the Multiple Sclerosis Disease Course: Tackling the Modifiable
Clinical and Treatment Considerations for the Pediatric and Aging Patients with Multiple Sclerosis
Women's Health and Pregnancy in Multiple Sclerosis
Multiple Sclerosis in Black and Hispanic Populations: Serving the Underserved
Era of COVID-19 in Multiple Sclerosis Care
Recent Advances in Diagnostic, Prognostic, and Disease-Monitoring Biomarkers in Multiple Sclerosis
Pathophysiology, Diagnosis, Treatment and Emerging Neurotherapeutic Targets for Progressive Multiple Sclerosis: The Age of PIRA
Relationship Between Multiple Sclerosis, Gut Dysbiosis, and Inflammation: Considerations for Treatment
Updates in NMOSD and MOGAD Diagnosis and Treatment: A Tale of Two Central Nervous System Autoimmune Inflammatory Disorders
Advances in Multiple Sclerosis Neurotherapeutics, Neuroprotection, and Risk Mitigation Strategies
Role of B Cells in Relapsing-Remitting and Progressive Multiple Sclerosis and Long-Term Effects of B Cell Depletion
Bruton's Tyrosine Kinase Inhibitors for Multiple Sclerosis Treatment: A New Frontier
Autologous Hematopoietic Stem Cell Transplantation to Treat Multiple Sclerosis
Highly Effective Therapy Versus Escalation Approaches in Early Multiple Sclerosis: What Is the Future of Multiple Sclerosis Treatment?
Leveraging Real-World Evidence and Observational Studies in Treating Multiple Sclerosis
Health, Wellness, and the Effect of Comorbidities on the Multiple Sclerosis Disease Course: Tackling the Modifiable
Clinical and Treatment Considerations for the Pediatric and Aging Patients with Multiple Sclerosis
Women's Health and Pregnancy in Multiple Sclerosis
Multiple Sclerosis in Black and Hispanic Populations: Serving the Underserved
Era of COVID-19 in Multiple Sclerosis Care